Processa Pharmaceuticals, Inc. (PCSA) Free cash flow 2016–2024
Processa Pharmaceuticals, Inc. (PCSA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$11.2MFY2024 · since FY2016: -$2.2M → -$11.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$11.2M | -39.5% |
| FY2023 | -$8.1M | — |
| FY2017 | -$1.7M | +23.1% |
| FY2016 | -$2.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice